National Research Declares Quarterly Dividend of $0.16
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 03 2026
0mins
Should l Buy NRC?
Source: seekingalpha
- Quarterly Dividend Announcement: National Research has declared a quarterly dividend of $0.16 per share, consistent with previous distributions, indicating the company's ongoing ability to maintain stable cash flow.
- Dividend Yield: The forward yield of 2.92% provides investors with a relatively stable return, enhancing the attractiveness of the company's stock in the market.
- Payment Schedule: The dividend will be payable on April 10, with a record date of March 27 and an ex-dividend date also on March 27, ensuring shareholders receive their earnings promptly.
- Investor Confidence: By maintaining the dividend level, National Research signals confidence in its financial health, potentially attracting more investors seeking stable income.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy NRC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on NRC
About NRC
National Research Corporation, doing business as NRC Health, is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare organizations in the United States. Its digital solutions consist of four solution categories: Patient Experience, Consumer Experience, Employee Experience, and Market Experience, which can be implemented both collectively as an enterprise solution or individually to meet specific needs within the organization. Its Marketing solutions are subscription-based services that allow for improved tracking of awareness, perception, and consistency of healthcare brands; real-time assessment of competitive differentiators, and enhanced segmentation tools. Its Reputation solutions allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs better consumer decision-making.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
NRC Health Expands Partnership with Lurie Children's Hospital
- Deepening Partnership: NRC Health announced an expanded partnership with Ann & Robert H. Lurie Children's Hospital in Chicago, adding reputation management services to its existing Market Insights and Patient Experience solutions, showcasing a mutual commitment to enhancing patient experiences.
- Digital Reputation Enhancement: This expansion enables Lurie Children's to gain better insights into its digital presence, integrating Market Insights with Reputation management to unify community perception, patient experience, and digital reputation into a more actionable strategy, thereby enhancing brand trust.
- Patient Experience and Trust: NRC Health COO Helen Hrdy emphasized that online reviews and digital presence are not merely brand considerations but critical signals influencing patient decision-making and organizational reputation, highlighting the close connection between patient experience and consumer insights.
- Industry Trend Reflection: This partnership expansion reflects a growing recognition in healthcare of the deep connections between reputation, experience, and consumer insights, indicating that the most competitive organizations in the future will be those that can view and act on these factors holistically.
See More
NRC Health Expands Partnership with Lurie Children’s Hospital
- Partnership Expansion: NRC Health has further expanded its partnership with Ann & Robert H. Lurie Children’s Hospital, adding Reputation solutions to its existing Market Insights and Patient Experience offerings, highlighting the hospital's commitment to patient experience.
- Digital Transformation: This expansion enhances the hospital's understanding of its digital presence, combining Market Insights with Reputation to improve influence over patient decision-making and organizational reputation.
- Enhanced Patient Experience: By integrating consumer insights with real-time visibility into online reviews, the hospital can unify community perception, patient experience, and digital reputation into a more actionable strategy, thereby strengthening patient trust and loyalty.
- Industry Trend Leadership: This collaboration underscores a growing recognition in healthcare of the deep connections between reputation, experience, and consumer insights, emphasizing that organizations best positioned for the future will be those that can view and act on these factors holistically.
See More
Piedmont Healthcare Partners with NRC Health for Experience Management
- Strategic Partnership: Piedmont Healthcare has partnered with NRC Health to enhance the overall experience for over 4.5 million patients served annually by integrating patient experience data and strengthening caregiver engagement, thereby driving mission-driven growth for the organization.
- Patient Experience Enhancement: This collaboration will leverage NRC Health's Patient Experience, Leader Rounding, and Market Insights solutions to optimize the experiences of patients, families, and employees across 27 hospitals and 2,000 locations, further enhancing patient loyalty.
- Community Impact: In Fiscal Year 2024, Piedmont provided over $607 million in community impact, demonstrating its strong presence and commitment to local communities, serving 85% of Georgia's population.
- Industry Recognition: Piedmont has been recognized by Newsweek as one of America's Greatest Workplaces for Diversity in 2023 and 2024, and was listed by Forbes as one of the Best Large Employers in the United States in 2022, showcasing its excellence in employee satisfaction and diversity.
See More
Analyst Blog Highlights Featured Stocks Update
- Oracle's Strong Earnings: Oracle's fiscal Q3 2026 results exceeded expectations with revenues and earnings, driven by an 84% surge in cloud infrastructure revenues, reflecting robust AI workload and multicloud demand, although the negative $13.2 billion free cash flow indicates ongoing investment pressures in data center expansions.
- T-Mobile's Underperformance: T-Mobile's shares have declined 10.1% over the past six months, underperforming the industry average, primarily due to high debt and fierce competition; however, its leading postpaid customer growth and record-low churn rate provide a competitive edge, particularly with its 5G spectrum strategy.
- Gilead's Sales Growth Outlook: Gilead's stock has risen 30.6% in the last six months, bolstered by its leading HIV portfolio, with expectations for approximately 6% growth in HIV sales in 2026, further supported by the approval of a long-acting injectable treatment that is expected to enhance revenue.
- National Research's Rising Contract Value: National Research has seen its Total Recurring Contract Value rise to approximately $152 million over five consecutive quarters, despite revenue declines and competitive pressures, indicating potential for future revenue growth supported by its extensive presence in U.S. healthcare systems.
See More
U.S. Stocks Rise as NIO Reports Strong Earnings
- Quarterly Revenue Surge: NIO reported quarterly revenue of 34.65 billion yuan ($4.95 billion), reflecting a year-over-year increase of 75.9% and a sequential rise of 59.0%, surpassing the analyst consensus estimate of $4.61 billion, indicating robust market demand and sales growth potential.
- Significant Earnings Improvement: The company's adjusted earnings came in at 0.29 yuan (4 cents) per ADS, a remarkable turnaround from a loss of 3.17 yuan per ADS a year earlier, exceeding expectations for a 5-cent loss, showcasing effective cost control and enhanced profitability.
- Stock Price Rally: Following the earnings report, NIO shares surged 10.6% to $5.47, reflecting investor optimism regarding the company's future growth prospects and potentially attracting more institutional investor interest.
- Overall Market Performance: The U.S. stock market rose overall, with the Dow Jones index gaining around 200 points on Tuesday, indicating increased confidence in economic recovery, which may provide a favorable investment environment for NIO and other tech stocks.
See More
National Research Corporation Authorizes $60 Million Stock Repurchase Program
- Repurchase Program Initiated: National Research Corporation (NRC) has authorized a stock repurchase program of up to $60 million, set to run through March 31, 2028, aimed at enhancing shareholder value and stabilizing stock prices.
- Stock Price Reaction: Following the announcement, NRC's stock fell 1.94% in after-hours trading to $14.68, indicating a cautious initial market response to the repurchase plan.
- Contract Value Growth: NRC's total recurring contract value has exceeded $152 million, demonstrating significant progress in stabilizing revenue sources, which supports future financial performance.
- Market Environment Analysis: Amid increasing market volatility, NRC's repurchase plan not only reflects the company's confidence in its own value but may also attract more investor interest due to its potential for high dividend yields.
See More
NRC Health Expands Partnership with Lurie Children's Hospital
- Deepening Partnership: NRC Health announced an expanded partnership with Ann & Robert H. Lurie Children's Hospital in Chicago, adding reputation management services to its existing Market Insights and Patient Experience solutions, showcasing a mutual commitment to enhancing patient experiences.
- Digital Reputation Enhancement: This expansion enables Lurie Children's to gain better insights into its digital presence, integrating Market Insights with Reputation management to unify community perception, patient experience, and digital reputation into a more actionable strategy, thereby enhancing brand trust.
- Patient Experience and Trust: NRC Health COO Helen Hrdy emphasized that online reviews and digital presence are not merely brand considerations but critical signals influencing patient decision-making and organizational reputation, highlighting the close connection between patient experience and consumer insights.
- Industry Trend Reflection: This partnership expansion reflects a growing recognition in healthcare of the deep connections between reputation, experience, and consumer insights, indicating that the most competitive organizations in the future will be those that can view and act on these factors holistically.
See More
NRC Health Expands Partnership with Lurie Children’s Hospital
- Partnership Expansion: NRC Health has further expanded its partnership with Ann & Robert H. Lurie Children’s Hospital, adding Reputation solutions to its existing Market Insights and Patient Experience offerings, highlighting the hospital's commitment to patient experience.
- Digital Transformation: This expansion enhances the hospital's understanding of its digital presence, combining Market Insights with Reputation to improve influence over patient decision-making and organizational reputation.
- Enhanced Patient Experience: By integrating consumer insights with real-time visibility into online reviews, the hospital can unify community perception, patient experience, and digital reputation into a more actionable strategy, thereby strengthening patient trust and loyalty.
- Industry Trend Leadership: This collaboration underscores a growing recognition in healthcare of the deep connections between reputation, experience, and consumer insights, emphasizing that organizations best positioned for the future will be those that can view and act on these factors holistically.
See More
Piedmont Healthcare Partners with NRC Health for Experience Management
- Strategic Partnership: Piedmont Healthcare has partnered with NRC Health to enhance the overall experience for over 4.5 million patients served annually by integrating patient experience data and strengthening caregiver engagement, thereby driving mission-driven growth for the organization.
- Patient Experience Enhancement: This collaboration will leverage NRC Health's Patient Experience, Leader Rounding, and Market Insights solutions to optimize the experiences of patients, families, and employees across 27 hospitals and 2,000 locations, further enhancing patient loyalty.
- Community Impact: In Fiscal Year 2024, Piedmont provided over $607 million in community impact, demonstrating its strong presence and commitment to local communities, serving 85% of Georgia's population.
- Industry Recognition: Piedmont has been recognized by Newsweek as one of America's Greatest Workplaces for Diversity in 2023 and 2024, and was listed by Forbes as one of the Best Large Employers in the United States in 2022, showcasing its excellence in employee satisfaction and diversity.
See More
Analyst Blog Highlights Featured Stocks Update
- Oracle's Strong Earnings: Oracle's fiscal Q3 2026 results exceeded expectations with revenues and earnings, driven by an 84% surge in cloud infrastructure revenues, reflecting robust AI workload and multicloud demand, although the negative $13.2 billion free cash flow indicates ongoing investment pressures in data center expansions.
- T-Mobile's Underperformance: T-Mobile's shares have declined 10.1% over the past six months, underperforming the industry average, primarily due to high debt and fierce competition; however, its leading postpaid customer growth and record-low churn rate provide a competitive edge, particularly with its 5G spectrum strategy.
- Gilead's Sales Growth Outlook: Gilead's stock has risen 30.6% in the last six months, bolstered by its leading HIV portfolio, with expectations for approximately 6% growth in HIV sales in 2026, further supported by the approval of a long-acting injectable treatment that is expected to enhance revenue.
- National Research's Rising Contract Value: National Research has seen its Total Recurring Contract Value rise to approximately $152 million over five consecutive quarters, despite revenue declines and competitive pressures, indicating potential for future revenue growth supported by its extensive presence in U.S. healthcare systems.
See More
U.S. Stocks Rise as NIO Reports Strong Earnings
- Quarterly Revenue Surge: NIO reported quarterly revenue of 34.65 billion yuan ($4.95 billion), reflecting a year-over-year increase of 75.9% and a sequential rise of 59.0%, surpassing the analyst consensus estimate of $4.61 billion, indicating robust market demand and sales growth potential.
- Significant Earnings Improvement: The company's adjusted earnings came in at 0.29 yuan (4 cents) per ADS, a remarkable turnaround from a loss of 3.17 yuan per ADS a year earlier, exceeding expectations for a 5-cent loss, showcasing effective cost control and enhanced profitability.
- Stock Price Rally: Following the earnings report, NIO shares surged 10.6% to $5.47, reflecting investor optimism regarding the company's future growth prospects and potentially attracting more institutional investor interest.
- Overall Market Performance: The U.S. stock market rose overall, with the Dow Jones index gaining around 200 points on Tuesday, indicating increased confidence in economic recovery, which may provide a favorable investment environment for NIO and other tech stocks.
See More
National Research Corporation Authorizes $60 Million Stock Repurchase Program
- Repurchase Program Initiated: National Research Corporation (NRC) has authorized a stock repurchase program of up to $60 million, set to run through March 31, 2028, aimed at enhancing shareholder value and stabilizing stock prices.
- Stock Price Reaction: Following the announcement, NRC's stock fell 1.94% in after-hours trading to $14.68, indicating a cautious initial market response to the repurchase plan.
- Contract Value Growth: NRC's total recurring contract value has exceeded $152 million, demonstrating significant progress in stabilizing revenue sources, which supports future financial performance.
- Market Environment Analysis: Amid increasing market volatility, NRC's repurchase plan not only reflects the company's confidence in its own value but may also attract more investor interest due to its potential for high dividend yields.
See More
